21GRAMS

What 21GRAMS does

21GRAMS is a healthcare-focused marketing, advertising, and patient/medical education agency serving pharmaceutical, biotech, medical device, and healthcare organizations. Founded in 2018, the firm has scaled to 251-500 employees and positions itself as "a different kind of healthcare agency" that holds healthcare communications to the same creative and strategic standards as leading consumer brands. Its service scope is described as full-service ("What can we do? Just about anything"), spanning brand strategy, creative campaigns, advertising, and patient education, though the source material does not enumerate specific named products, modules, or distinct service lines.

The company operates a dual-headquartered model with a North American HQ in New York (199 Water Street, 14th Floor) and a Global HQ in London (10 Chiswell Street, 7th Floor), enabling transatlantic coverage of the two largest pharmaceutical marketing geographies. The underlying technology stack is not publicly disclosed, and the firm is positioned as a services business rather than a platform or SaaS provider. Recruitment and talent operations are hosted on Real Chemistry's Greenhouse job board, suggesting an organizational or operational affiliation with the larger Real Chemistry healthcare-marketing network.

21GRAMS was acquired by PostNord Strålfors from Banqup Group on 2026-04-07; financial terms were not disclosed. Prior to the acquisition, no funding rounds, revenue figures, or detailed ownership history are documented in the source data. Founder/CEO Robert Blink leads the firm, with account leadership such as Account Director Adrianna Aguayo disclosed. Customer logos, pricing model, and revenue mechanics are not publicly available, limiting visibility into commercial structure.

Name

21GRAMS

Website

https://21gramsny.com

Company type

Private

Founded year

2018

Operating status

Acquired

Headcount range

251–500 employees

Short description

21GRAMS is a healthcare-focused marketing, advertising, and patient education agency serving pharmaceutical, biotech, medical device, and healthcare clients from dual headquarters in New York and London, founded in 2018 and recently acquired by PostNord Strålfors.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

21GRAMS is a strategic and creative marketing, advertising, and patient/medical education agency purpose-built for the healthcare industry. It serves pharmaceutical, biotech, medical device, and healthcare organizations with full-service brand, communications, and creative capabilities, applying consumer-brand standards to healthcare work.

Product overview

21GRAMS is a healthcare agency that positions itself as a different kind of healthcare marketing firm. The company operates from North American headquarters in New York, NY and global headquarters in London, UK. The source data does not provide specific named products, modules, or distinct service offerings beyond general descriptions of their agency services (Our Name, Our Mission, Our People, Our Way, Our Work).

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Marketing and Advertising Services Full-service strategic marketing and advertising agency services for pharmaceutical, biotech, medical device, and healthcare organizations, applying consumer-brand creative standards to healthcare communications.
• Patient and Medical Education Patient and medical education content and communications services for healthcare clients, delivered as part of the firm's full-service agency offering.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• PostNord StrålforsacquisitionOthers · 7 April 2026PostNord Strålfors acquired 21GRAMS from Banqup Group in April 2026. The acquisition represents PostNord Strålfors expanding its capabilities in the healthcare communications space. Financial terms of the deal were not disclosed.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Real Chemistry: Real Chemistry is a large independent healthcare marketing and communications agency with deep pharma and biotech client relationships. 21GRAMS' careers portal is hosted on Real Chemistry's Greenhouse job board, indicating direct operational overlap, and the two compete for the same healthcare-brand creative mandates.
• W2O Group: W2O is a healthcare-focused communications, marketing, and analytics firm serving pharma, biotech, and medical-device clients. It competes head-to-head with 21GRAMS for integrated healthcare communications and creative mandates, and similarly emphasizes data-driven and brand-quality work.
• Intouch Group: Intouch Group is a healthcare marketing agency serving pharma, biotech, and medical-device clients with creative, digital, and media services. It is a direct peer competing with 21GRAMS on the same pharma/consumer-brand-quality axis.
• Patients & Purpose: Patients & Purpose is a healthcare communications agency that helps brands connect with patients and caregivers through creative and strategic work. It is a direct peer competing with 21GRAMS for consumer-grade healthcare creative mandates.
• Saatchi & Saatchi Wellness: Saatchi & Saatchi Wellness is a Publicis-owned agency focused on health and wellness brand communications. It is a direct peer of 21GRAMS in healthcare brand creative, with network advantages but a similar consumer-grade creative thesis.
• Evoke (formerly Evoke Health): Evoke is a healthcare marketing and communications agency within the Huntsworth Health network serving pharma, biotech, and consumer-health clients. It is a direct peer competing with 21GRAMS on integrated brand and creative work for healthcare clients.

Broad incumbents

• Havas Health & You: Havas Health & You is the global health and wellness communications network of Havas, serving pharma, consumer health, and wellness clients. It is a broad incumbent offering overlapping creative and brand communications capabilities to 21GRAMS' target clients at network scale.
• Publicis Health: Publicis Health is the global healthcare communications arm of Publicis Groupe, offering creative, media, and data services across pharma and consumer health. It is a broad incumbent that overlaps with 21GRAMS across most healthcare creative and brand mandates but at significantly greater scale and network reach.
• Omnicom Health Group: Omnicom Health Group is the healthcare-specialized network of Omnicom, comprising multiple agency brands serving pharma and biotech clients. It is a broad incumbent that competes with 21GRAMS for large global launches and brand-of-the-brand assignments through its portfolio agencies.
• Syneos Health Communications: Syneos Health Communications is the communications and advertising arm of Syneos Health, focused on biopharma and healthcare clients with integrated communications offerings. It is a broad incumbent competing with 21GRAMS for healthcare creative and brand engagements, especially on clinical-stage and launch work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/21gramsworld

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 21GRAMS